Investment Boom

Cue up "We're in the Money," please, this time for life sciences businesses. Venture Capital funds are flowing freely into the life sciences sector so far this year – up 25 percent by value in the second quarter, according to a new analysis.

The new MoneyTree report from PriceWaterhouse Cooper's and the National Venture Capital Association finds that VCs pumped $2.5 billion into life sciences deals in the second quarter, compared to $2 billion in the same period last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.